NANJING, China, March 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly growing China market, announced today that it intends to release its 2008 fourth quarter and full year results on Thursday, March 12, 2009, before the market opens in the United States. Simcere's chief executive officer, Jinsheng Ren, and chief financial officer, Frank Zhigang Zhao, will host an earnings conference call to discuss the company's 2008 fourth quarter and full year results on Thursday, March 12, at 8 a.m. ET (Thursday, March 12, at 8 p.m. Beijing/Hong Kong time).
To access the conference call, please dial: United States toll-free dial-in number: +1.866.700.7477 United States dial-in number: +1.617.213.8840 North China toll-free dial-in number: 10.800.152.1490 South China toll-free dial-in number: 10.800.130.0399 Hong Kong dial-in number: +852.3002.1672
Please ask to be connected to Simcere's Q4 2008 earnings call and provide the following passcode: 77163710. Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at http://www.simcere.com .
Following the earnings conference call, an archive of the call will be available by dialing:
United States toll-free dial-in number: +1.888.286.8010
United States dial-in number: +1.617.801.6888
The passcode for replay participants is: 92927155. The telephone replay
also will be archived on the "Investor Relations" section of the company's web
site for s
|SOURCE Simcere Pharmaceutical Group|
Copyright©2009 PR Newswire.
All rights reserved